je.st
news
Tag: virus
WHO starts special meeting on Zika virus
2016-02-01 17:44:42| Biotech - Topix.net
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. On Friday, Jan. 15, 2016, U.S. health officials are telling pregnant women to avoid travel to Latin America and Caribbean countries with outbreaks of a tropical illness linked to birth defects.
Tags: special
meeting
starts
virus
Six people being tested for Zika virus in Bexar County
2016-01-31 04:50:02| Biotech - Topix.net
This 2006 photo provided by the Centers for Disease Control and Prevention shows a female Aedes aegypti mosquito in the process of acquiring a blood meal from a human host. On Friday, Jan. 15, 2016, U.S. health officials are telling pregnant women to avoid travel to Latin America and Caribbean countries with outbreaks of a tropical illness linked to birth defects.
Tags: people
county
tested
virus
State confirms 3 SC residents tested for Zika virus
2016-01-31 00:59:09| Biotech - Topix.net
Health officials say three people in South Carolina are being tested for the Zika virus, but no cases of the disease have been confirmed yet. Department official Dr. Teresa Foo tells local media that the chances of getting Zika virus in South Carolina are minuscule.
Tags: state
tested
virus
residents
What to know right now about Zika virus
2016-01-30 04:29:00| Climate Ark Climate Change & Global Warming Newsfeed
Mother Nature Network: Zika virus was an obscure illness until recently, especially in the Americas. But now it's "spreading explosively" through the New World, the World Health Organization (WHO) warned this week at an emergency meeting about the outbreak. Zika could infect up to 4 million people before the end of 2016, according to WHO director-general Margaret Chan, who says the virus has gone "from a mild threat to one of alarming proportions." Although Zika has been known to science for seven decades, it's only...
Tags: virus
Merck Receives FDA Approval of ZEPATIER (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
2016-01-29 00:59:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. ZEPATIER Achieves High Cure Rates (SVR12) in Broad Range of Patients with Chronic Hepatitis C Infection, Including Those with Compensated Cirrhosis, Renal Impairment of Any Degree and HIV-1/HCV Co-infection KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved ZEPATIER (elbasvir and grazoprevir) for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype (GT) 1 or GT4 infection, with or without ribavirin (RBV), following priority review by the FDA. Language: English Contact: MerckMedia:Doris Li, 908-246-5701Sarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
following
review
treatment
Sites : [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] next »